IFNA1 and cancer: Similarly, in vivo propagation of CIN+ tumors in immuno-proficient mice, but not immuno-deficient mice, led to decreased inflammatory signaling in the CIN+ cancer cells evidenced by a reduced IFN response and decreased MHC class I antigen presentation (Tripathi et al. 2019).